192 related articles for article (PubMed ID: 24480222)
1. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
Qu Q; Wang S; Chen S; Zhou L; Rui JA
Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
3. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors influencing postoperative survival in patients with Wu FS; Zhao WH; Liang TB; Ren GP; Ma ZM; Teng LS
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):579-83. PubMed ID: 15938929
[TBL] [Abstract][Full Text] [Related]
6. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
9. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
10. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
12. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
[TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
[TBL] [Abstract][Full Text] [Related]
14. Survival factors after resection of small hepatocellular carcinoma.
Wu FS; Zhao WH; Liang TB; Ma ZM; Teng LS; Wang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):379-84. PubMed ID: 16109520
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
16. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J
Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
20. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
